Intranasal phosphoramidon increases beta-amyloid levels in wild-type and NEP/NEP2-deficient mice.

Item

http://www.wikidata.org/entity/Q44115717

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Intranasal phosphoramidon incr ...... e and NEP/NEP2-deficient mice.

@en

Intranasal phosphoramidon incr ...... e and NEP/NEP2-deficient mice.

@nl

type

Item

label

Intranasal phosphoramidon incr ...... e and NEP/NEP2-deficient mice.

@en

Intranasal phosphoramidon incr ...... e and NEP/NEP2-deficient mice.

@nl

prefLabel

Intranasal phosphoramidon incr ...... e and NEP/NEP2-deficient mice.

@en

Intranasal phosphoramidon incr ...... e and NEP/NEP2-deficient mice.

@nl

P1476

Intranasal phosphoramidon incr ...... e and NEP/NEP2-deficient mice.

@en

P2093

Aleta L Svitak

http://www.w3.org/2001/XMLSchema#string

Daniel Hafez

http://www.w3.org/2001/XMLSchema#string

Leah R Hanson

http://www.w3.org/2001/XMLSchema#string

Rachel B Burns

http://www.w3.org/2001/XMLSchema#string

Robert A Marr

http://www.w3.org/2001/XMLSchema#string

William H Frey

http://www.w3.org/2001/XMLSchema#string

Xuan Li

http://www.w3.org/2001/XMLSchema#string

P2860

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition

Molecular identification and characterization of novel membrane-bound metalloprotease, the soluble secreted form of which hydrolyzes a variety of vasoactive peptides

Intranasal delivery of cells to the brain.

Reduced fertility in male mice deficient in the zinc metallopeptidase NL1

Neutral endopeptidase modulation of septic shock.

Human membrane metallo-endopeptidase-like protein degrades both beta-amyloid 42 and beta-amyloid 40.

Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke.

A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.

Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

P2888

s12031-010-9460-8

P304

424-427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12031-010-9460-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47404913

http://www.w3.org/2001/XMLSchema#string

P698

20941644

http://www.w3.org/2001/XMLSchema#string